Immune cell and gastrointestinal mucosal receptors

The term 'Immune cell and gastrointestinal mucosal receptors' refers to a broad functional category of molecules that coordinate the migration, retention, and activation of immune cells within the gastrointestinal (GI) tract. This system is primarily defined by the 'gut-homing' axis, where integrins such as alpha-4 beta-7 on lymphocytes interact with the mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expressed on the intestinal vascular endothelium (PubMed, 2023). Other key components include the chemokine receptor CCR9, which responds to mucosal signals, and sphingosine-1-phosphate (S1P) receptors, which regulate the exit of lymphocytes from lymphoid tissues into the circulation (PMC, 2023). These receptors are critical in the pathogenesis of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, where their dysregulation leads to the excessive accumulation of inflammatory cells in the gut wall (NIH, 2022). Therapeutic agents like vedolizumab and ozanimod target these receptors to provide gut-selective immunosuppression, offering a targeted alternative to systemic steroids by preserving immune function in non-GI tissues (StatPearls, 2023). This class of receptors represents a major focus in the development of precision therapies for chronic inflammatory and autoimmune conditions of the gut.

Other names

Gut-homing receptorsMucosal immune receptorsIntestinal homing receptorsLymphocyte trafficking receptorsMucosal addressin receptors

Inhibition of lymphocyte trafficking to the gastrointestinal mucosa by blocking the interaction between immune cell receptors (e.g., alpha-4 beta-7 integrin, CCR9) and their respective mucosal ligands (e.g., MAdCAM-1, CCL25), or by modulating lymphocyte egress from lymphoid organs via sphingosine-1-phosphate (S1P) receptors.